349 related articles for article (PubMed ID: 25446950)
1. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.
Rajasekaran A; Venkatasubramanian G; Berk M; Debnath M
Neurosci Biobehav Rev; 2015 Jan; 48():10-21. PubMed ID: 25446950
[TBL] [Abstract][Full Text] [Related]
2. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.
Venkatasubramanian G; Debnath M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():301-11. PubMed ID: 23587629
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
Anderson G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
5. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications.
Debnath M; Cannon DM; Venkatasubramanian G
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():49-62. PubMed ID: 22813842
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
Clay HB; Sillivan S; Konradi C
Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways of mitochondrial dysfunctions: possible cause of cell death in anesthesia-induced developmental neurotoxicity.
Li L; Yu Q; Liang W
Brain Res Bull; 2015 Jan; 110():14-9. PubMed ID: 25451455
[TBL] [Abstract][Full Text] [Related]
8. Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.
Altamura AC; Buoli M; Pozzoli S
Psychiatry Clin Neurosci; 2014 Jan; 68(1):21-36. PubMed ID: 24102953
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria, synaptic plasticity, and schizophrenia.
Ben-Shachar D; Laifenfeld D
Int Rev Neurobiol; 2004; 59():273-96. PubMed ID: 15006492
[TBL] [Abstract][Full Text] [Related]
10. Redox dysregulation, neurodevelopment, and schizophrenia.
Do KQ; Cabungcal JH; Frank A; Steullet P; Cuenod M
Curr Opin Neurobiol; 2009 Apr; 19(2):220-30. PubMed ID: 19481443
[TBL] [Abstract][Full Text] [Related]
11. Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.
Davis J; Moylan S; Harvey BH; Maes M; Berk M
Aust N Z J Psychiatry; 2014 Jun; 48(6):512-29. PubMed ID: 24803587
[TBL] [Abstract][Full Text] [Related]
12. Molecular links between mitochondrial dysfunctions and schizophrenia.
Park C; Park SK
Mol Cells; 2012 Feb; 33(2):105-10. PubMed ID: 22358509
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
Ben-Shachar D
Schizophr Res; 2017 Sep; 187():3-10. PubMed ID: 27802911
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in health and disease: perspectives on a new mitochondrial biology.
Duchen MR
Mol Aspects Med; 2004 Aug; 25(4):365-451. PubMed ID: 15302203
[TBL] [Abstract][Full Text] [Related]
15. Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.
Debnath M
J Neuroimmune Pharmacol; 2015 Dec; 10(4):610-9. PubMed ID: 26162591
[TBL] [Abstract][Full Text] [Related]
16. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria.
James R; Adams RR; Christie S; Buchanan SR; Porteous DJ; Millar JK
Mol Cell Neurosci; 2004 May; 26(1):112-22. PubMed ID: 15121183
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine.
Ben-Shachar D
J Neurochem; 2002 Dec; 83(6):1241-51. PubMed ID: 12472879
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging.
Wang CH; Wu SB; Wu YT; Wei YH
Exp Biol Med (Maywood); 2013 May; 238(5):450-60. PubMed ID: 23856898
[TBL] [Abstract][Full Text] [Related]
19. Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment.
Suárez-Méndez S; García-de la Cruz DD; Tovilla-Zárate CA; Genis-Mendoza AD; Ramón-Torres RA; González-Castro TB; Juárez-Rojop IE
Prog Biophys Mol Biol; 2020 Sep; 155():36-41. PubMed ID: 32437701
[TBL] [Abstract][Full Text] [Related]
20. Putative neuroprotective agents in neuropsychiatric disorders.
Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
